文献速递胃肠外科围术期管理与 ERAS

老年胃癌患者胃切除术后延长随访:复发后生存改善但无总生存获益

Extended follow-up after gastrectomy in elderly patients: Improved postrecurrence survival but no overall survival benefit in patients aged 73 years or older.
PubMed 文献 · Surgery · 2025-10-27

基于韩国国民健康保险索赔数据库21,902例65岁以上胃切除术后5年无复发患者,比较规律与不规律随访的总生存,发现延长规律随访的生存获益仅限65-72岁,73岁及以上无总生存获益。在12,295例73岁及以上无病生存5年患者中,922例(7.5%)发生晚期复发或残胃癌,该组延长规律随访与复发后生存改善显著相关(5年生存51.8% vs 24.3%,P<.001)。

要点

  • 延长规律随访的总生存获益仅见于65-72岁患者,73岁及以上未观察到。
  • 73岁及以上术后5年无病生存者中7.5%发生晚期复发或残胃癌。
  • 该人群延长规律随访改善复发后生存(5年51.8% vs 24.3%)。

核心结论

  • 在73岁及以上胃切除术后5年无复发患者中,延长规律随访改善复发后生存但不改善总生存。
  • 对该人群的随访策略需结合整体健康状况和潜在获益进行个体化制定。

研究设计与样本

  • 回顾性队列研究,数据来自韩国国民健康保险索赔数据库。
  • 纳入21,902例65岁及以上胃切除术后5年内无复发或其他癌症的胃癌患者。
  • 比较规律与不规律随访组的总生存,确定无额外生存获益的年龄切点。
  • 在年龄切点以上且发生晚期复发或残胃癌的患者中评估随访对复发后生存的影响。

主要发现

  • 延长规律随访的生存获益仅限65-72岁患者,73岁及以上未观察到,故将73岁定义为切点。
  • 12,295例73岁及以上且术后5年无病生存患者中,922例(7.5%)发生晚期复发或残胃癌。
  • 该组中延长规律随访与复发后生存改善显著相关(5年生存51.8% vs 24.3%,P<.001)。
  • 内镜或计算机断层扫描随访间隔超过2年与更差的生存结局相关。

临床怎么用

  • 对73岁及以上胃切除术后5年无复发患者,应个体化制定随访策略,权衡复发后生存获益与总生存无改善。
  • 避免内镜或CT随访间隔超过2年,因其与更差生存相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our previous cohort study suggested potential survival benefits of extended follow-up beyond 5 years in survivors of gastric cancer. However, its clinical value in elderly patients with varying health status and life expectancy remains unclear. METHODS: Overall, 21,902 patients with gastric cancer aged ≥65 years without recurrence or other cancers within 5 years postgastrectomy were extracted from the Korean National Health Insurance claims database. Overall survival was compared between regular and irregular follow-up groups to determine a cut-off age beyond which no additional survival benefit was observed. In patients above this age with late recurrence or gastric remnant cancer, the impact of follow-up on postrecurrence survival was assessed. RESULTS: The survival benefit of extended regular follow-up was limited to patients aged 65-72 years and was not observed in those aged ≥73 years, which was defined as the cut-off. Among the 12,295 patients aged ≥73 years who remained disease-free for 5 years after gastrectomy, 922 (7.5%) developed late recurrence or gastric remnant cancer. In this group, extended regular follow-up was significantly associated with improved postrecurrence survival (5-year survival: 51.8% vs 24.3%, P < .001). In addition, follow-up intervals longer than 2 years for either endoscopy or computed tomography were associated with poorer survival outcomes. CONCLUSION: Extended follow-up improved postrecurrence survival but not overall survival in patients aged ≥73 years. These findings suggest that follow-up strategies for this population may need to be individualized, considering overall health status and potential benefit.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Lee DG, Kim J, Lee JH, et al. Extended follow-up after gastrectomy in elderly patients: Improved postrecurrence survival but no overall survival benefit in patients aged 73 years or older. Surgery. 2025. PMID: 41151490. doi:10.1016/j.surg.2025.109821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。